Dimitri Kullmann FRS FMedSci MAE
Dimitri Kullmann at the Royal Society, London, 2018
Born	Dimitri Michael Kullmann 1958 (age 65–66) [4] London, England [4]
Education	Lycée Français Charles de Gaulle [4]
Alma mater	University of Oxford (BM BCh, DPhil)
Awards	Baly Medal (2017) [1]
Scientific career
Fields	Neuroscience [2] Synaptic transmission [2] Channelopathies [2] Epilepsy [2]
Institutions	University College London University of California, San Francisco [1] National Hospital for Neurology and Neurosurgery UCL Institute of Neurology
Thesis	Central actions of muscle receptors (1984)
Doctoral advisor	Julian Jack [3]
Website	www.ucl.ac.uk/ion/research/synaptopathies/principal-investigators/dimitri-m-kullmann

Dimitri Michael Kullmann (born 1958) ^[4] FRS FMedSci MAE is a professor of neurology at the UCL Institute of Neurology, ^[1] University College London (UCL), and leads the synaptopathies initiative funded by the Wellcome Trust. ^[5] Kullmann is a member of the Queen Square Institute of Neurology Department of Clinical and Experimental Epilepsy ^[6] and a consultant neurologist at the National Hospital for Neurology and Neurosurgery. ^{[2] [7]}

Education

Kullmann was educated at the Lycée Français Charles de Gaulle ^[4] and studied physiology at Balliol College, Oxford ^[4] where he was awarded a Bachelor of Arts (BA) degree and a Doctor of Philosophy degree. ^[3] He studied and trained at the University of Oxford and St Thomas's Hospital Medical School at the University of London. ^[1] His postgraduate research was supervised by Julian Jack. ^[3]

Research and career

Kullmann's research ^{[2] [7]} investigates how synapses function in health and disease. ^[8] His laboratory helped to show how neurotransmitters activate different receptor subtypes in and around synapses, and resolved some controversies about the mechanisms of long-term changes in synaptic strength. ^[8] Genetic and autoimmune disorders of synaptic proteins (‘ synaptopathies’) provide insights into the mechanisms of a broad range of neurological diseases including epilepsy and migraine. ^[8] Together with his colleagues, Kullmann has used these insights to devise gene therapy strategies that could be used to treat intractable epilepsy. ^{[8] [2]}

The Kullmann lab ^{[2] [7]} has contributed to the discovery and elucidation of silent synapses, ^[9] glutamate spillover, tonic inhibition, ^[10] long-term potentiation in interneurons, ^[11] neurological channelopathies ^[12] and Synaptopathies, gene therapy for epilepsy, ^[13] and mechanisms of neural oscillations. ^[14] Kullmann served as the editor-in-chief of the scientific journal Brain between 2014 and 2020 ^[15] and is on the editorial board of the journal Neuron. ^[16] Before working at UCL, he did postdoctoral research with Roger Nicoll at the University of California, San Francisco. ^[1]

Awards and honours

Kullmann was awarded the University Gold Medal in Medicine by the University of London, in 1986. ^[1] and the Baly Medal by the Royal College of Physicians in 2017. ^[1] He was elected a Guarantor of Brain in 2000, ^[17] elected a Fellow of the Academy of Medical Sciences (FMedSci) in 2001, ^[18] a Corresponding Fellow of the American Neurological Association in 2013, ^[19] a member of the Academia Europaea (MAE) in 2017 ^[20] and a Fellow of the Royal Society (FRS) in 2018. ^[8]

References

 This article incorporates text available under the CC BY 4.0 license.